Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcello Arca

Showing results (11-20 of 212) with videos related to

Pageof 22
Sort By:
Current Opinion in Lipidology|February 6, 2020
Familial combined hypolipidemia: angiopoietin-like protein-3 deficiencyMarcello Arca, Laura D'Erasmo, Ilenia Minicocci
Current Opinion in Lipidology|July 11, 2013
The angiopoietin-like protein 3: a hepatokine with expanding role in metabolismMarcello Arca, Ilenia Minicocci, Marianna Maranghi
Current Atherosclerosis Reports|September 1, 2021
Rare Treatments for Rare Dyslipidemias: New Perspectives in the Treatment of Homozygous Familial Hypercholesterolemia (HoFH) and Familial Chylomicronemia Syndrome (FCS)Laura D'Erasmo, Simone Bini, Marcello Arca
Giornale Italiano Di Cardiologia (2006)|April 13, 2021
[Dyslipidemias: new therapeutic targets and relevance of combination therapies]Marcello Arca, Stefania Angela Di Fusco
Current Opinion in Endocrinology, Diabetes, and Obesity|November 10, 2025
Lessons from recent clinical trials for the prevention of acute pancreatitis in chylomicronemia syndromesLaura D'Erasmo, Daniele Tramontano, Marcello Arca
Current Opinion in Lipidology|February 4, 2020
Autosomal recessive hypercholesterolemia: update for 2020Laura D'Erasmo, Alessia Di Costanzo, Marcello Arca
Liver International : Official Journal of the International Association for the Study of the Liver|December 15, 2022
Long-term hepatic safety of lomitapide in homozygous familial hypercholesterolaemiaDominique Larrey, Laura D'Erasmo, Sallyann O'Brien, et al.
Current Opinion in Lipidology|October 7, 2022
Recent Apolipoprotein CIII trialsDaniele Tramontano, Simone Bini, Laura D'Erasmo, et al.
Journal of Clinical Lipidology|October 13, 2022
A mechanism-based operational definition and classification of hypercholesterolemiaFernando Civeira, Marcello Arca, Ana Cenarro, et al.
Giornale Italiano Di Cardiologia (2006)|March 9, 2021
[Does the STRENGTH trial confirm or deny previous evidence on the role of n-3 polyunsaturated fatty acids for the prevention of cardiovascular events?]Leonardo De Luca, Massimo Uguccioni, Pier Luigi Temporelli, et al.
Pageof 22

Showing results (11-20 of 212) with videos related to

Sort By:
Pageof 22
Current Opinion in Lipidology|February 6, 2020
Familial combined hypolipidemia: angiopoietin-like protein-3 deficiencyMarcello Arca, Laura D'Erasmo, Ilenia Minicocci
Current Opinion in Lipidology|July 11, 2013
The angiopoietin-like protein 3: a hepatokine with expanding role in metabolismMarcello Arca, Ilenia Minicocci, Marianna Maranghi
Current Atherosclerosis Reports|September 1, 2021
Rare Treatments for Rare Dyslipidemias: New Perspectives in the Treatment of Homozygous Familial Hypercholesterolemia (HoFH) and Familial Chylomicronemia Syndrome (FCS)Laura D'Erasmo, Simone Bini, Marcello Arca
Giornale Italiano Di Cardiologia (2006)|April 13, 2021
[Dyslipidemias: new therapeutic targets and relevance of combination therapies]Marcello Arca, Stefania Angela Di Fusco
Current Opinion in Endocrinology, Diabetes, and Obesity|November 10, 2025
Lessons from recent clinical trials for the prevention of acute pancreatitis in chylomicronemia syndromesLaura D'Erasmo, Daniele Tramontano, Marcello Arca
Current Opinion in Lipidology|February 4, 2020
Autosomal recessive hypercholesterolemia: update for 2020Laura D'Erasmo, Alessia Di Costanzo, Marcello Arca
Liver International : Official Journal of the International Association for the Study of the Liver|December 15, 2022
Long-term hepatic safety of lomitapide in homozygous familial hypercholesterolaemiaDominique Larrey, Laura D'Erasmo, Sallyann O'Brien, et al.
Current Opinion in Lipidology|October 7, 2022
Recent Apolipoprotein CIII trialsDaniele Tramontano, Simone Bini, Laura D'Erasmo, et al.
Journal of Clinical Lipidology|October 13, 2022
A mechanism-based operational definition and classification of hypercholesterolemiaFernando Civeira, Marcello Arca, Ana Cenarro, et al.
Giornale Italiano Di Cardiologia (2006)|March 9, 2021
[Does the STRENGTH trial confirm or deny previous evidence on the role of n-3 polyunsaturated fatty acids for the prevention of cardiovascular events?]Leonardo De Luca, Massimo Uguccioni, Pier Luigi Temporelli, et al.
Pageof 22